Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-02-002112
Filing Date
2002-03-14
Accepted
2002-03-14 00:00:00
Documents
5
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR END DECEMBER 31, 2001 d94574e10-k.txt 10-K 331527
3 STOCK PLAN d94574ex10-27.txt EX-10.27 37742
4 SEVERANCE AGREEMENT d94574ex10-28.txt EX-10.28 10230
5 STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE d94574ex11-1.txt EX-11.1 3413
6 CONSENT OF ARTHUR ANDERSEN LLP d94574ex23.txt EX-23 566
  Complete submission text file 0000950134-02-002112.txt   385498
Mailing Address 14785 OMICRON DR SUITE 101 SAN ANTONIO TX 78245
Business Address 4545 HORIZON HILL BLVD SAN ANTONIO TX 78229 2109498200
ILEX ONCOLOGY INC (Filer) CIK: 0001001915 (see all company filings)

EIN.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22147 | Film No.: 02575385
SIC: 2836 Biological Products, (No Diagnostic Substances)